Frazier Life Sciences Management’s Structure Therapeutics GPCR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-629,194	Closed	-$27M	–	53
2024 Q1	$27M	Buy	629,194 +312,004	+98%	+$13.4M	1.14%	26
2023 Q4	$12.9M	Buy	+317,190	New	+$12.9M	0.69%	37